Antifibrotic effect of total flavonoids of Astmgali Radix on dimethylnitrosamine-induced liver cirrhosis in rats.
- Author:
Yang CHENG
1
;
Jing-Yin MAI
2
;
Mei-Feng WANG
3
;
Gao-Feng CHEN
3
;
Jian PING
3
Author Information
- Publication Type:Journal Article
- Keywords: dimethylnitrosamine; farnesoid X receptor; liver cirrhosis; peroxisome proliferatoractivated receptor γ; rat; total flavonoids of Astmgali Radix; uncoupling protein 2
- MeSH: Actins; metabolism; Animals; Blotting, Western; Body Weight; drug effects; Collagen Type I; metabolism; Dimethylnitrosamine; Drugs, Chinese Herbal; pharmacology; therapeutic use; Flavonoids; pharmacology; therapeutic use; Hydroxyproline; metabolism; Liver; drug effects; pathology; Liver Cirrhosis; blood; drug therapy; genetics; pathology; Male; Organ Size; drug effects; PPAR gamma; genetics; metabolism; Plant Extracts; pharmacology; therapeutic use; RNA, Messenger; genetics; metabolism; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Cytoplasmic and Nuclear; genetics; metabolism; Uncoupling Protein 2; genetics; metabolism
- From: Chinese journal of integrative medicine 2017;23(1):48-54
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo study the effect of total flavonoids of Astmgali Radix (TFA) on liver cirrhosis induced with dimethylnitrosamine (DMN) in rats, and the effect on peroxisome proliferator-activated receptor γ (PPARγ), uncoupling protein 2 (UCP2) and farnesoid X receptor (FXR).
METHODSFifty-three Sprague-Dawley rats were randomly divided into a control group (10 rats) and a DMN group (43 rats). Rats in the DMN group were given DMN for 4 weeks and divided randomly into a model group (14 rats), a low-dosage TFA group (14 rats) and a high-dosage TFA group (15 rats) in the 3rd week. Rats were given TFA for 4 weeks at the dosage of 15 and 30 mg/kg in the low- and high-TFA groups, respectively. At the end of the experiment blood and liver samples were collected. Serum liver function and liver tissue hydroxyproline content were determined. hematoxylin-eosin (HE), Sirus red and immunohistochemical stainings of collagen I, smooth muscle actin (α-SMA) was conducted in paraffinembedded liver tissue slices. Real time polymerase chain reaction (PCR) was adopted to determine PPARγ, UCP2 and FXR mRNA levels. Western blot was adopted to determine protein levels of collagen I, α-SMA, PPARγ, UCP2 and FXR.
RESULTSCompared with the model group, TFA increased the ratio of liver/body weight (low-TFA group P<0.05, high-TFA group P<0.01), improved liver biochemical indices (P<0.01 for ALT, AST, GGT in both groups, P<0.05 for albumin and TBil in the high-TFA group) and reduced liver tissue hydroxproline content (P<0.01 in both groups) in treatment groups significantly. HE staining showed that TFA alleviated liver pathological changes markedly and Sirus red staining showed that TFA reduced collagen deposition, alleviated formation and extent of liver pseudolobule. Collagen I and α-SMA immunohistochemical staining showed that staining area and extent markedly decreased in TFA groups compared with the model group. TFA could increase PPARγ, it regulated target UCP2, and FXR levels significantly compared with the model group (in the low-TFA group all P<0.05, in the high group all P<0.01).
CONCLUSIONTFA could improve liver function, alleviate liver pathological changes, and reduce collagen deposition and formation of liver pseudolobule in rats with liver cirrhosis. The antifibrotic effect of TFA was through regulating PPARγ signal pathway and the interaction with FXR.
